Metabolic signaling as new concept for breast cancer risk estimation

HITS is partner of the international research consortium “MESI-STRAT” that explores the interplay of breast cancer metabolism and oncogenic signaling by systems medicine. The consortium was awarded by the European Union €6 million for five years. The main goal of the five-years project is to develop new models for knowledge-based stratification of patients into subgroups to guide targeted interventions. The Scientific Databases and Visualization (SDBV) group at HITS takes care of the model and data management platform.